Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0003198 | HP:0003198 | Myopathy | 0 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003198 | Myopathy | 0 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003198 | Myopathy | 0 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003198 | Myopathy | 0 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003198 | Myopathy | 0 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003198 | Myopathy | 0 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003198 | Myopathy | 0 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003198 | Myopathy | 0 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003198 | Myopathy | 0 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003198 | Myopathy | 0 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003198 | Myopathy | 0 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003198 | Myopathy | 0 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003198 | Myopathy | 0 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003198 | Myopathy | 0 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003198 | Myopathy | 0 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003198 | Myopathy | 0 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003198 | Myopathy | 0 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003198 | Myopathy | 0 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003198 | Myopathy | 0 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003198 | Myopathy | 0 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003198 | Myopathy | 0 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003198 | Myopathy | 0 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003198 | Myopathy | 0 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003198 | Myopathy | 0 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003198 | Myopathy | 0 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003198 | Myopathy | 0 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ABHD5 CL E G H | 51099 | 275630 | Triglyceride storage disease with ichthyosis | 275630 | C0268238 | OMIM | 1 | | 291 | 21396 | 604780 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACACA CL E G H | 31 | 613933 | Acetyl-CoA: carboxylase deficiency | 613933 | C0268603 | OMIM | 1 | | 307 | 84 | 200350 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACADS CL E G H | 35 | 201470 | Deficiency of butyryl-CoA dehydrogenase | 201470 | C0342783 | OMIM | 1 | | 406 | 90 | 606885 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACTA1 CL E G H | 58 | 97244 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ADGRG6 CL E G H | 57211 | 616503 | Lethal congenital contracture syndrome 9 | 616503 | C4225303 | OMIM | 1 | | 153 | 13841 | 612243 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ADSSL1 CL E G H | 122622 | 617030 | Myopathy, distal, 5 | 617030 | C4310754 | OMIM | 1 | | | 20093 | 612498 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AGK CL E G H | 55750 | 1369 | | | | ORPHA | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AGL CL E G H | 178 | 366 | Arnold Stickler Bourne syndrome | | | ORPHA | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AGL CL E G H | 178 | 232400 | Glycogen storage disease type III | 232400 | C0017922 | OMIM | 1 | | 2263 | 321 | 610860 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AGPAT2 CL E G H | 10555 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 242 | 325 | 603100 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ALG14 CL E G H | 199857 | 353327 | | | | ORPHA | 1 | | 144 | 28287 | 612866 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ALG2 CL E G H | 85365 | 353327 | | | | ORPHA | 1 | | 335 | 23159 | 607905 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ALPL CL E G H | 249 | 241510 | Childhood hypophosphatasia | 241510 | C0220743 | OMIM | 1 | | 934 | 438 | 171760 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | AP1S2 CL E G H | 8905 | 85329 | | | | ORPHA | 1 | | 241 | 560 | 300629 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | B3GALNT2 CL E G H | 148789 | 588 | | | | ORPHA | 1 | | 587 | 28596 | 610194 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | B4GALT1 CL E G H | 2683 | 79332 | | | | ORPHA | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | B4GALT1 CL E G H | 2683 | 607091 | Congenital disorder of glycosylation type 2D | 607091 | C1846816 | OMIM | 1 | | 184 | 924 | 137060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | BSCL2 CL E G H | 26580 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CAPN3 CL E G H | 825 | 618129 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4 | 618129 | CN253839 | OMIM | 1 | | 1521 | 1480 | 114240 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CASQ1 CL E G H | 844 | 88635 | | | | ORPHA | 1 | | 249 | 1512 | 114250 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CAV1 CL E G H | 857 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 135 | 1527 | 601047 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CAVIN1 CL E G H | 284119 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 128 | 9688 | 603198 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CCDC174 CL E G H | 51244 | 616816 | Hypotonia, infantile, with psychomotor retardation | 616816 | C4225196 | OMIM | 1 | | 87 | 28033 | 616735 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CENPF CL E G H | 1063 | 243605 | Stromme syndrome | 243605 | C1855705 | OMIM | 1 | | 554 | 1857 | 600236 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CHKB CL E G H | 1120 | 602541 | Muscular dystrophy, congenital, megaconial type | 602541 | C1865233 | OMIM | 1 | | 502 | 1938 | 612395 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CHRNB1 CL E G H | 1140 | 616313 | Myasthenic syndrome, congenital, 2a, slow-channel | 616313 | C4225374 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CHRNB1 CL E G H | 1140 | 616314 | Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency | 616314 | C4225373 | OMIM | 1 | | 454 | 1961 | 100710 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CHRND CL E G H | 1144 | 616321 | Myasthenic syndrome, congenital, 3a, slow-channel | 616321 | C4225372 | OMIM | 1 | | 505 | 1965 | 100720 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CHRNE CL E G H | 1145 | 605809 | Myasthenic syndrome, congenital, 4a, slow-channel | 605809 | C1853949 | OMIM | 1 | | 1011 | 1966 | 100725 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COL12A1 CL E G H | 1303 | 616471 | Bethlem myopathy 2 | 616471 | C4225313 | OMIM | 1 | | 2548 | 2188 | 120320 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COL6A1 CL E G H | 1291 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1718 | 2211 | 120220 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COL6A2 CL E G H | 1292 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 1928 | 2212 | 120240 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COL6A3 CL E G H | 1293 | 158810 | Bethlem myopathy 1 | 158810 | CN029274 | OMIM | 1 | | 3001 | 2213 | 120250 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COLQ CL E G H | 8292 | 98915 | | | | ORPHA | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | COLQ CL E G H | 8292 | 603034 | Endplate acetylcholinesterase deficiency | 603034 | C1864233 | OMIM | 1 | | 542 | 2226 | 603033 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CPT2 CL E G H | 1376 | 228305 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CPT2 CL E G H | 1376 | 228302 | | | | ORPHA | 1 | | 876 | 2330 | 600650 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DNA2 CL E G H | 1763 | 352470 | | | | ORPHA | 1 | | 601 | 2939 | 601810 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DPAGT1 CL E G H | 1798 | 353327 | | | | ORPHA | 1 | | 312 | 2995 | 191350 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DYSF CL E G H | 8291 | 606768 | Myopathy, distal, with anterior tibial onset | 606768 | C1847532 | OMIM | 1 | | 3355 | 3097 | 603009 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | EMD CL E G H | 2010 | 310300 | Emery-Dreifuss muscular dystrophy 1, X-linked | 310300 | C0751337 | OMIM | 1 | | 695 | 3331 | 300384 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | EPG5 CL E G H | 57724 | 242840 | Vici syndrome | 242840 | C1855772 | OMIM | 1 | | 1640 | 29331 | 615068 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ERGIC1 CL E G H | 57222 | 208100 | Arthrogryposis multiplex congenita neurogenic type | 208100 | C1859721 | OMIM | 1 | | 39 | 29205 | 617946 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FHL1 CL E G H | 2273 | 300695 | Scapuloperoneal myopathy, X-linked dominant | 300695 | C2678061 | OMIM | 1 | | 586 | 3702 | 300163 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKBP14 CL E G H | 55033 | 300179 | | | | ORPHA | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKBP14 CL E G H | 55033 | 614557 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss | 614557 | C3281160 | OMIM | 1 | | 220 | 18625 | 614505 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKRP CL E G H | 79147 | 588 | | | | ORPHA | 1 | | 950 | 17997 | 606596 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKTN CL E G H | 2218 | 588 | | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKTN CL E G H | 2218 | 272 | VACTERL hydrocephaly | | | ORPHA | 1 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FLNC CL E G H | 2318 | 614065 | Myopathy, distal, 4 | 614065 | C3279722 | OMIM | 1 | | 4208 | 3756 | 102565 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FOS CL E G H | 2353 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 40 | 3796 | 164810 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GCLC CL E G H | 2729 | 230450 | Gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to | 230450 | C1856603 | OMIM | 1 | | 128 | 4311 | 606857 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GFER CL E G H | 2671 | 613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay | 613076 | C2751320 | OMIM | 1 | | 200 | 4236 | 600924 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GFPT1 CL E G H | 2673 | 353327 | | | | ORPHA | 1 | | 524 | 4241 | 138292 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GK CL E G H | 2710 | 307030 | Deficiency of glycerol kinase | 307030 | C0268418 | OMIM | 1 | | 233 | 4289 | 300474 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GMPPB CL E G H | 29925 | 588 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GMPPB CL E G H | 29925 | 353327 | | | | ORPHA | 1 | | 364 | 22932 | 615320 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HADHA CL E G H | 3030 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 792 | 4801 | 600890 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HADHB CL E G H | 3032 | 609015 | Mitochondrial trifunctional protein deficiency | 609015 | C0342786 | OMIM | 1 | | 367 | 4803 | 143450 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HNRNPA1 CL E G H | 3178 | 615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | 615424 | C3809469 | OMIM | 1 | | 80 | 5031 | 164017 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HNRNPA2B1 CL E G H | 3181 | 615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | 615422 | C3809468 | OMIM | 1 | | 295 | 5033 | 600124 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HNRNPDL CL E G H | 9987 | 609115 | Limb-girdle muscular dystrophy, type 1G | 609115 | C1836765 | OMIM | 1 | | 354 | 5037 | 607137 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | HSPG2 CL E G H | 3339 | 800 | | | | ORPHA | 1 | | 2497 | 5273 | 142461 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | INPP5K CL E G H | 51763 | 559 | | | | ORPHA | 1 | | 187 | 33882 | 607875 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ITGA7 CL E G H | 3679 | 613204 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | 613204 | C2750786 | OMIM | 1 | | 898 | 6143 | 600536 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LAMB2 CL E G H | 3913 | 98915 | | | | ORPHA | 1 | | 915 | 6487 | 150325 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LARGE1 CL E G H | 9215 | 588 | | | | ORPHA | 1 | | 786 | 6511 | 603590 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMNA CL E G H | 4000 | 157973 | | | | ORPHA | 1 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMNB2 CL E G H | 84823 | 79087 | | | | ORPHA | 1 | | 548 | 6638 | 150341 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ATP6 CL E G H | 4508 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ATP6 CL E G H | 4508 | 551500 | Neuropathy ataxia retinitis pigmentosa syndrome | 551500 | C1328349 | OMIM | 1 | | | 7414 | 516060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO1 CL E G H | 4512 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7419 | 516030 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO2 CL E G H | 4513 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7421 | 516040 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO3 CL E G H | 4514 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO3 CL E G H | 4514 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7422 | 516050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CYB CL E G H | 4519 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CYB CL E G H | 4519 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7427 | 516020 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND1 CL E G H | 4535 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND1 CL E G H | 4535 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7455 | 516000 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND2 CL E G H | 4536 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7456 | 516001 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND4 CL E G H | 4538 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7459 | 516003 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND4L CL E G H | 4539 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7460 | 516004 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND5 CL E G H | 4540 | 551 | | | | ORPHA | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND5 CL E G H | 4540 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND5 CL E G H | 4540 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7461 | 516005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND6 CL E G H | 4541 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND6 CL E G H | 4541 | 535000 | Leber's optic atrophy | 535000 | C0917796 | OMIM | 1 | | | 7462 | 516006 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-RNR1 CL E G H | 4549 | 551 | | | | ORPHA | 1 | | 1 | 7470 | 180450 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TC CL E G H | 4511 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7477 | 590020 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TE CL E G H | 4556 | 254864 | | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TF CL E G H | 4558 | 551 | | | | ORPHA | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TF CL E G H | 4558 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TF CL E G H | 4558 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7481 | 590070 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TH CL E G H | 4564 | 551 | | | | ORPHA | 1 | | | 7487 | 590040 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TI CL E G H | 4565 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7488 | 590045 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TK CL E G H | 4566 | 551 | | | | ORPHA | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TK CL E G H | 4566 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TK CL E G H | 4566 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7489 | 590060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TL1 CL E G H | 4567 | 551 | | | | ORPHA | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TL1 CL E G H | 4567 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TL1 CL E G H | 4567 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7490 | 590050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TP CL E G H | 4571 | 551 | | | | ORPHA | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TP CL E G H | 4571 | 545000 | Myoclonus with epilepsy with ragged red fibers | 545000 | C0162672 | OMIM | 1 | | | 7494 | 590075 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TQ CL E G H | 4572 | 551 | | | | ORPHA | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TQ CL E G H | 4572 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7495 | 590030 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TS1 CL E G H | 4574 | 551 | | | | ORPHA | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TS1 CL E G H | 4574 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7497 | 590080 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TS2 CL E G H | 4575 | 551 | | | | ORPHA | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TS2 CL E G H | 4575 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7498 | 590085 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TT CL E G H | 4576 | 551000 | Lethal infantile mitochondrial myopathy | 551000 | C1838876 | OMIM | 1 | | | 7499 | 590090 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TV CL E G H | 4577 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7500 | 590105 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-TW CL E G H | 4578 | 540000 | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 540000 | C0162671 | OMIM | 1 | | | 7501 | 590095 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYH2 CL E G H | 4620 | 605637 | Inclusion body myopathy 3 | 605637 | C1854106 | OMIM | 1 | | 1161 | 7572 | 160740 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYMK CL E G H | 389827 | 254940 | Congenital nonprogressive myopathy with Moebius and Robin sequences | 254940 | C1850746 | OMIM | 1 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYO18B CL E G H | 84700 | 616549 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | 616549 | C4225285 | OMIM | 1 | | 1810 | 18150 | 607295 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYOT CL E G H | 9499 | 182920 | Spheroid body myopathy | 182920 | C1866785 | OMIM | 1 | | 372 | 12399 | 604103 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NARS2 CL E G H | 79731 | 616239 | Combined oxidative phosphorylation deficiency 24 | 616239 | C4015643 | OMIM | 1 | | 302 | 26274 | 612803 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NDUFA11 CL E G H | 126328 | 618236 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 | 618236 | | OMIM | 1 | | 131 | 20371 | 612638 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NDUFAF1 CL E G H | 51103 | 618234 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 | 618234 | | OMIM | 1 | | 154 | 18828 | 606934 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NDUFAF4 CL E G H | 29078 | 618237 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 | 618237 | | OMIM | 1 | | 136 | 21034 | 611776 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NDUFB3 CL E G H | 4709 | 618246 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 | 618246 | | OMIM | 1 | | 79 | 7698 | 603839 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NEFH CL E G H | 4744 | 616924 | Charcot-Marie-Tooth disease, axonal, type 2CC | 616924 | C4310790 | OMIM | 1 | | 714 | 7737 | 162230 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NUBPL CL E G H | 80224 | 618242 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 618242 | | OMIM | 1 | | 284 | 20278 | 613621 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | OPA1 CL E G H | 4976 | 125250 | Autosomal dominant optic atrophy plus syndrome | 125250 | C1852267 | OMIM | 1 | | 1224 | 8140 | 605290 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ORAI1 CL E G H | 84876 | 612782 | Immune dysfunction with T-cell inactivation due to calcium entry defect 1 | 612782 | C2748568 | OMIM | 1 | | 326 | 25896 | 610277 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PABPN1 CL E G H | 8106 | 270 | | | | ORPHA | 1 | | 85 | 8565 | 602279 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PANK2 CL E G H | 80025 | 234200 | Pigmentary pallidal degeneration | 234200 | C0018523 | OMIM | 1 | | 499 | 15894 | 606157 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PLEC CL E G H | 5339 | 257 | | | | ORPHA | 1 | | 5068 | 9069 | 601282 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PNPLA2 CL E G H | 57104 | 98908 | | | | ORPHA | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | POMGNT1 CL E G H | 55624 | 588 | | | | ORPHA | 1 | | 1174 | 19139 | 606822 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | POMT1 CL E G H | 10585 | 588 | | | | ORPHA | 1 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | POMT2 CL E G H | 29954 | 588 | | | | ORPHA | 1 | | 936 | 19743 | 607439 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PPARG CL E G H | 5468 | 528 | Acute myeloblastic leukemia type 3 | | | ORPHA | 1 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PRKAG2 CL E G H | 51422 | 261740 | Glycogen storage disease of heart, lethal congenital | 261740 | C1849813 | OMIM | 1 | | 1079 | 9386 | 602743 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PUS1 CL E G H | 80324 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 478 | 15508 | 608109 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PYGM CL E G H | 5837 | 368 | | | | ORPHA | 1 | | 1055 | 9726 | 608455 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RET CL E G H | 5979 | 162300 | Multiple endocrine neoplasia, type 2b | 162300 | C0025269 | OMIM | 1 | | 3165 | 9967 | 164761 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RMND1 CL E G H | 55005 | 614922 | Combined oxidative phosphorylation deficiency 11 | 614922 | C3554067 | OMIM | 1 | | 262 | 21176 | 614917 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RYR1 CL E G H | 6261 | 597 | | | | ORPHA | 1 | | 6164 | 10483 | 180901 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SCN4A CL E G H | 6329 | 613345 | Hypokalemic periodic paralysis, type 2 | 613345 | C2750061 | OMIM | 1 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SELENON CL E G H | 57190 | 97244 | | | | ORPHA | 1 | | 651 | 15999 | 606210 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SGCB CL E G H | 6443 | 119 | | | | ORPHA | 1 | | 500 | 10806 | 600900 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SIL1 CL E G H | 64374 | 559 | | | | ORPHA | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SIL1 CL E G H | 64374 | 248800 | Marinesco-Sjögren syndrome | 248800 | C0024814 | OMIM | 1 | | 352 | 24624 | 608005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SLC22A5 CL E G H | 6584 | 212140 | Renal carnitine transport defect | 212140 | C0342788 | OMIM | 1 | | 1027 | 10969 | 603377 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SLC25A3 CL E G H | 5250 | 91130 | | | | ORPHA | 1 | | 176 | 10989 | 600370 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SLC25A4 CL E G H | 291 | 1369 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | STIM1 CL E G H | 6786 | 612783 | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 | 612783 | C2748557 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | STIM1 CL E G H | 6786 | 160565 | Myopathy with tubular aggregates | 160565 | C0410207 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | STIM1 CL E G H | 6786 | 185070 | Stormorken syndrome | 185070 | C1861451 | OMIM | 1 | | 635 | 11386 | 605921 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TIA1 CL E G H | 7072 | 603 | | | | ORPHA | 1 | | 250 | 11802 | 603518 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TNNT1 CL E G H | 7138 | 605355 | Nemaline myopathy 5 | 605355 | C1854380 | OMIM | 1 | | 372 | 11948 | 191041 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TPI1 CL E G H | 7167 | 615512 | Triosephosphate isomerase deficiency | 615512 | C1860808 | OMIM | 1 | | 181 | 12009 | 190450 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TRAPPC11 CL E G H | 60684 | 369840 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TRAPPC11 CL E G H | 60684 | 369847 | | | | ORPHA | 1 | | 983 | 25751 | 614138 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TRIM32 CL E G H | 22954 | 1878 | Chromosome 1, uniparental disomy 1q12 q21 | | CN035970 | ORPHA | 1 | | 627 | 16380 | 602290 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TRMU CL E G H | 55687 | 254864 | | | | ORPHA | 1 | | 623 | 25481 | 610230 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TTN CL E G H | 7273 | 611705 | Myopathy, early-onset, with fatal cardiomyopathy | 611705 | C2673677 | OMIM | 1 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | UBA1 CL E G H | 7317 | 301830 | Spinal muscular atrophy, X-linked 2 | 301830 | C1844934 | OMIM | 1 | | 631 | 12469 | 314370 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | VCP CL E G H | 7415 | 167320 | Inclusion body myopathy with early-onset paget disease and frontotemporal dementia | 167320 | C1833662 | OMIM | 1 | | 607 | 12666 | 601023 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | VMA21 CL E G H | 203547 | 310440 | Myopathy, X-linked, with excessive autophagy | 310440 | C1839615 | OMIM | 1 | | 254 | 22082 | 300913 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 1 | | 2362 | 1908 | 605978 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | XDH CL E G H | 7498 | 278300 | Deficiency of xanthine oxidase | 278300 | C0268118 | OMIM | 1 | | 691 | 12805 | 607633 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | XK CL E G H | 7504 | 300842 | McLeod neuroacanthocytosis syndrome | 300842 | C0398568 | OMIM | 1 | | 218 | 12811 | 314850 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | YARS2 CL E G H | 51067 | 2598 | Mitochondrial myopathy and sideroblastic anemia | | CN220387 | ORPHA | 1 | | 274 | 24249 | 610957 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ZBTB20 CL E G H | 26137 | 3042 | | | | ORPHA | 1 | | 252 | 13503 | 606025 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0003198 | HP:0003198 | Myopathy | 0 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003198 | Myopathy | 0 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003198 | Myopathy | 0 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0003198 | Myopathy | 0 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003198 | Myopathy | 0 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003198 | Myopathy | 0 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003198 | Myopathy | 0 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003198 | Myopathy | 0 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003198 | Myopathy | 0 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003198 | Myopathy | 0 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0003198 | Myopathy | 0 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003198 | Myopathy | 0 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003198 | Myopathy | 0 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003198 | Myopathy | 0 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003198 | Myopathy | 0 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003198 | Myopathy | 0 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003198 | Myopathy | 0 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003198 | Myopathy | 0 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003198 | Myopathy | 0 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0003198 | Myopathy | 0 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003198 | Myopathy | 0 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003198 | Myopathy | 0 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003458 | EMG: myopathic abnormalities | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0003715 | Myofibrillar myopathy | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0003756 | Skeletal myopathy | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0003789 | Minicore myopathy | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0009071 | Inflammatory myopathy | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0008978 | Necrotizing myopathy | 1 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ABCC9 CL E G H | 10060 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1507 | 60 | 601439 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACTA1 CL E G H | 58 | 171436 | | | | ORPHA | 0 | | 506 | 129 | 102610 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACTC1 CL E G H | 70 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 672 | 143 | 102540 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ACTN2 CL E G H | 88 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1361 | 164 | 102573 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ALDOA CL E G H | 226 | 611881 | HNSHA due to aldolase A deficiency | 611881 | C0272066 | OMIM | 0 | | 504 | 414 | 103850 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ANKRD1 CL E G H | 27063 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 442 | 15819 | 609599 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | BAG3 CL E G H | 9531 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 986 | 939 | 603883 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | BAZ1B CL E G H | 9031 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 249 | 961 | 605681 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | BSCL2 CL E G H | 26580 | 363400 | | | | ORPHA | 0 | | 510 | 15832 | 606158 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CACNA1S CL E G H | 779 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1886 | 1397 | 114208 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CDH23 CL E G H | 64072 | 96253 | | | | ORPHA | 0 | | 4522 | 13733 | 605516 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CFL2 CL E G H | 1073 | 171436 | | | | ORPHA | 0 | | 167 | 1875 | 601443 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CISD2 CL E G H | 493856 | 3463 | | | | ORPHA | 0 | | 71 | 24212 | 611507 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CLIP2 CL E G H | 7461 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 229 | 2586 | 603432 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CRYAB CL E G H | 1410 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 273 | 2389 | 123590 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CSRP3 CL E G H | 8048 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 407 | 2472 | 600824 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | CTNS CL E G H | 1497 | 219800 | Nephropathic cystinosis | 219800 | C0010690 | OMIM | 0 | | 778 | 2518 | 606272 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DES CL E G H | 1674 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 976 | 2770 | 125660 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DMD CL E G H | 1756 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 8184 | 2928 | 300377 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DOLK CL E G H | 22845 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 521 | 23406 | 610746 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | DSG2 CL E G H | 1829 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1570 | 3049 | 125671 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | ELN CL E G H | 2006 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 966 | 3327 | 130160 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FHL2 CL E G H | 2274 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 200 | 3703 | 602633 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | FKTN CL E G H | 2218 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 914 | 3622 | 607440 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GABRD CL E G H | 2563 | 1606 | | | | ORPHA | 0 | | 474 | 4084 | 137163 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GATAD1 CL E G H | 57798 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 618 | 29941 | 614518 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GTF2I CL E G H | 2969 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 178 | 4659 | 601679 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | GTF2IRD1 CL E G H | 9569 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 266 | 4661 | 604318 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | KCNAB2 CL E G H | 8514 | 1606 | | | | ORPHA | 0 | | 114 | 6229 | 601142 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | KLHL41 CL E G H | 10324 | 171436 | | | | ORPHA | 0 | | 294 | 16905 | 607701 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LAMA4 CL E G H | 3910 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1613 | 6484 | 600133 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LDB3 CL E G H | 11155 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1226 | 15710 | 605906 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LIMK1 CL E G H | 3984 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 232 | 6613 | 601329 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMNA CL E G H | 4000 | 2348 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMNA CL E G H | 4000 | 280365 | | | | ORPHA | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMNA CL E G H | 4000 | 610140 | Heart-hand syndrome, Slovenian type | 610140 | C1857829 | OMIM | 0 | | 1814 | 6636 | 150330 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | LMOD3 CL E G H | 56203 | 171436 | | | | ORPHA | 0 | | 392 | 6649 | 616112 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ATP6 CL E G H | 4508 | 104 | | | | ORPHA | 0 | | | 7414 | 516060 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO1 CL E G H | 4512 | 104 | | | | ORPHA | 0 | | | 7419 | 516030 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CO3 CL E G H | 4514 | 104 | | | | ORPHA | 0 | | | 7422 | 516050 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-CYB CL E G H | 4519 | 104 | | | | ORPHA | 0 | | | 7427 | 516020 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND1 CL E G H | 4535 | 104 | | | | ORPHA | 0 | | | 7455 | 516000 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND2 CL E G H | 4536 | 104 | | | | ORPHA | 0 | | | 7456 | 516001 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND4 CL E G H | 4538 | 104 | | | | ORPHA | 0 | | | 7459 | 516003 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND4L CL E G H | 4539 | 104 | | | | ORPHA | 0 | | | 7460 | 516004 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND5 CL E G H | 4540 | 104 | | | | ORPHA | 0 | | | 7461 | 516005 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MT-ND6 CL E G H | 4541 | 104 | | | | ORPHA | 0 | | | 7462 | 516006 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MTAP CL E G H | 4507 | 112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | 112250 | C1862177 | OMIM | 0 | | 251 | 7413 | 156540 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYBPC3 CL E G H | 4607 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3317 | 7551 | 600958 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYH6 CL E G H | 4624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2116 | 7576 | 160710 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYH7 CL E G H | 4625 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 4106 | 7577 | 160760 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYMK CL E G H | 389827 | 1358 | | | | ORPHA | 0 | | 86 | 33778 | 615345 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | MYPN CL E G H | 84665 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1485 | 23246 | 608517 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NDUFS2 CL E G H | 4720 | 104 | | | | ORPHA | 0 | | 247 | 7708 | 602985 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NEB CL E G H | 4703 | 171436 | | | | ORPHA | 0 | | 8530 | 7720 | 161650 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NEBL CL E G H | 10529 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1016 | 16932 | 605491 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | NEXN CL E G H | 91624 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 669 | 29557 | 613121 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PDE11A CL E G H | 50940 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 203 | 8773 | 604961 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PDE8B CL E G H | 8622 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 243 | 8794 | 603390 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 0 | | 346 | 8896 | 311800 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PLN CL E G H | 5350 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 178 | 9080 | 172405 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | POMT1 CL E G H | 10585 | 86812 | | | | ORPHA | 0 | | 906 | 9202 | 607423 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PPARG CL E G H | 5468 | 79083 | | | | ORPHA | 0 | | 166 | 9236 | 601487 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PPCS CL E G H | 79717 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 204 | 25686 | 609853 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PRDM16 CL E G H | 63976 | 1606 | | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PRDM16 CL E G H | 63976 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1272 | 14000 | 605557 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PRKACA CL E G H | 5566 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 43 | 9380 | 601639 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PRKAR1A CL E G H | 5573 | 189439 | Primary pigmented nodular adrenocortical disease | | CN200645 | ORPHA | 0 | | 1131 | 9388 | 188830 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PSEN1 CL E G H | 5663 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 501 | 9508 | 104311 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PSEN2 CL E G H | 5664 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 279 | 9509 | 600759 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | PTEN CL E G H | 5728 | 109 | Bannayan-Riley-Ruvalcaba syndrome | | C0265326 | ORPHA | 0 | | 3012 | 9588 | 601728 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RAF1 CL E G H | 5894 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 990 | 9829 | 164760 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RBM20 CL E G H | 282996 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1623 | 27424 | 613171 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RERE CL E G H | 473 | 1606 | | | | ORPHA | 0 | | 659 | 9965 | 605226 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | RFC2 CL E G H | 5982 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 200 | 9970 | 600404 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SCN4A CL E G H | 6329 | 682 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SCN4A CL E G H | 6329 | 99734 | | | | ORPHA | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SCN4A CL E G H | 6329 | 170400 | Hypokalemic periodic paralysis 1 | 170400 | C3714580 | OMIM | 0 | | 1765 | 10591 | 603967 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SCN5A CL E G H | 6331 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 3531 | 10593 | 600163 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SDHA CL E G H | 6389 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 2503 | 10680 | 600857 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SDHD CL E G H | 6392 | 100093 | | | | ORPHA | 0 | | 686 | 10683 | 602690 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SGCD CL E G H | 6444 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 673 | 10807 | 601411 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | SKI CL E G H | 6497 | 1606 | | | | ORPHA | 0 | | 1062 | 10896 | 164780 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TAF1A CL E G H | 9015 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 49 | 11532 | 604903 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TAZ CL E G H | 6901 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | | 11577 | 300394 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TBCE CL E G H | 6905 | 2323 | Triple-Negative Breast Cancer Finding | | C2348819 | ORPHA | 0 | | 456 | 11582 | 604934 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TBL2 CL E G H | 26608 | 904 | Blepharophimosis nasal groove growth retardation | | | ORPHA | 0 | | 194 | 11586 | 605842 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TCAP CL E G H | 8557 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 298 | 11610 | 604488 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TMPO CL E G H | 7112 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 597 | 11875 | 188380 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TNNC1 CL E G H | 7134 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 300 | 11943 | 191040 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TNNI3 CL E G H | 7137 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 655 | 11947 | 191044 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TNNT2 CL E G H | 7139 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 817 | 11949 | 191045 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TPM1 CL E G H | 7168 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 767 | 12010 | 191010 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TPM2 CL E G H | 7169 | 171436 | | | | ORPHA | 0 | | 341 | 12011 | 190990 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TTN CL E G H | 7273 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 27503 | 12403 | 188840 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | TXNRD2 CL E G H | 10587 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1068 | 18155 | 606448 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | USP8 CL E G H | 9101 | 96253 | | | | ORPHA | 0 | | 158 | 12631 | 603158 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | VCL CL E G H | 7414 | 154 | Sandhaus Ben-Ami syndrome | | | ORPHA | 0 | | 1175 | 12665 | 193065 |
HP:0003198 | HP:0003787 | Type 1 and type 2 muscle fiber minicore regions | 2 | WFS1 CL E G H | 7466 | 3463 | | | | ORPHA | 0 | | 1634 | 12762 | 606201 |